Call for Speaker Proposals
第3届
Personalized Diagnostics
-个别化诊断学会-
对临床医学的影响
2月21日～23日
个别化诊断若能作临床应用，就能把患者分阶层、以分子水平来分类疾病，判断发生的可能性，提出能最佳的治疗法。这样的方法不仅有助于削减医疗费和改善治疗，亦能成为实现消费者以自己意思进入医疗信息环境的力量。此学会选择有助于研究与临床应用的技术，亦聚焦于将新的研究成果转换成有效商务模式的方法。
Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Diagnostics, Business Development, R&D, Chemistry, Clinical Research, in vitro Diagnostics, Personalized Healthcare, Process Development, and Oncology.
Topics will include, but are not limited to:
- Third generation sequencing as a clinical tool
- Integrating molecular and cell-based diagnostics
- Leveraging epigenetics, gene mutation analysis, and gene expression assays
- Using proteomics as a diagnostic tool
- Mass spec to find and monitor biomarkers in blood
- NGS for mitochondrial disease diagnostics
- Assembling gene panels
- NGS data management
- RNA sequencing
The deadline for submission is July 29, 2011.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
